Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights
Stock Information for Jounce Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.